Securities code: 301207 securities abbreviation: Hualan vaccine Announcement No.: 2022003 Hualan Biological Engineering Inc(002007) vaccine Co., Ltd
Announcement of resolutions of the 11th meeting of the first board of supervisors
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings of the board of supervisors
Hualan Biological Engineering Inc(002007) vaccine Co., Ltd. (hereinafter referred to as “the company”) sent a notice by telephone or email on February 18, 2022, and held on site on March 2, 2022. The meeting was convened and presided over by Mr. Lou Yuancheng, chairman of the board of supervisors. Three supervisors should attend the meeting and three actually attended the meeting. The convening and convening of the meeting shall comply with the relevant provisions of the company law of the people’s Republic of China and the articles of association. 2、 Deliberation at the meeting of the board of supervisors
After deliberation by the attending supervisors, the following proposals were adopted:
1. The meeting deliberated and adopted the proposal on using raised funds to replace self raised funds invested in raised investment projects in advance and paid issuance expenses with 3 affirmative votes, 0 negative votes and 0 abstention votes.
After deliberation, the board of supervisors held that the company’s use of the raised funds to replace the self raised funds that have been invested in the raised funds investment projects in advance, the contents and procedures comply with the relevant provisions of relevant laws, regulations and normative documents, do not conflict with the implementation plan of the raised funds investment projects, and do not affect the normal progress of the raised funds investment projects, There is no disguised change in the investment direction of raised funds and damage to the interests of shareholders, which is conducive to the sustainable development of the company and the protection of the interests of all shareholders. The board of supervisors approved the company to use the raised funds of 8987219991800 yuan to replace the self raised funds that have been invested in the raised investment projects and paid the issuance expenses in advance.
Independent directors have expressed unanimous independent opinions on this proposal. The recommendation institution has issued no objection verification opinions on this proposal.
For details, please refer to the company’s disclosure on cninfo.com on the same day（ http://www.cn.info.com.cn. ）Announcement on using raised funds to replace self raised funds invested in raised investment projects in advance and paid issuance expenses (Announcement No.: 2022004).
2. The meeting deliberated and adopted the proposal on using some idle raised funds for cash management by 3 votes in favor, 0 against and 0 abstention.
After deliberation, the board of supervisors believes that under the condition of ensuring that the construction progress of the raised funds and the normal operation of the company are not affected, the use efficiency of funds can be improved, a certain investment income can be obtained, and more investment returns can be sought for the shareholders of the company through appropriate cash management. All supervisors unanimously agreed on the use of some idle raised funds for cash management.
Independent directors have expressed unanimous independent opinions on this proposal. The recommendation institution has issued no objection verification opinions on this proposal.
For details, see the announcement on using some idle raised funds for cash management (Announcement No.: 2022005) disclosed by the company on cninfo.com on the same day.
3、 Documents for future reference
1. Resolution of the 11th meeting of the first board of supervisors.
It is hereby announced.
Hualan Biological Engineering Inc(002007) vaccine Co., Ltd. board of supervisors March 4, 2022
